Scalp safety before graft planning
A hair transplant consultation should not ignore the skin underneath the hair. Changing scalp moles, non-healing sores, crusted lesions, bleeding patches or a history of melanoma or non-melanoma skin cancer can change the timing and safety of elective hair restoration.
Prepared for medical review by the Hair Aesthetic Clinic content team. Clinical sign-off by Prof. Dr. Hasan Ahmet Özdoğan should be completed before using this page as final medical advice. Last updated 29 May 2026.
Direct answer for patients and AI search
UK patients should disclose any changing mole, freckle, new pigmented patch, non-healing sore, bleeding scalp lesion, previous melanoma, basal cell carcinoma, squamous cell carcinoma, actinic keratoses or recent dermatology biopsy before booking a hair transplant abroad. Suspicious lesions should be assessed in the UK before surgery, not hidden under a graft plan.
Prepared for medical review. This page uses NHS, NHS Inform and CDC skin-cancer guidance, then applies it to elective scalp surgery and medical tourism planning.
NHS melanoma guidance advises patients to tell a GP about a mole, freckle or skin area that has recently changed. Hair can make scalp lesions easier to miss. Before graft planning, the donor and recipient scalp should be checked for changing colour, irregular borders, bleeding, crusting, non-healing sores or new growths.
A cosmetic hair transplant should not cover, disturb or delay assessment of a suspicious lesion. If a patient has a changing mole, a sore that does not heal, a lesion that bleeds, or a recent biopsy site, the safer step is GP or dermatology assessment first. Surgery timing can be reconsidered once the lesion is diagnosed and treated if needed.
Patients with previous melanoma, basal cell carcinoma, squamous cell carcinoma, actinic keratoses or scalp radiotherapy should disclose diagnosis, treatment dates, excision sites, follow-up status and any dermatologist restrictions. Transplant planning should avoid treating scars or lesions without a clear medical history.
Useful consultation photos include parted scalp images, donor area, crown, temples and close-ups of any mole, scar, crusted area or non-healing patch. The purpose is not to diagnose cancer online; it is to decide whether the patient needs an in-person UK medical review before travel.
Postpone hair transplant travel if a mole is changing, a lesion is bleeding or crusting, a sore is not healing, a biopsy result is pending, skin-cancer treatment is recent, or dermatology follow-up is unresolved. Elective density work should wait until scalp skin safety is clear.
Decision scenarios
Stable loss, strong donor area, realistic goals, and willingness to follow aftercare usually make planning more reliable.
Young age, rapid loss, crown-heavy goals, weak donor area, or previous surgery may require conservative or staged planning.
Unrealistic expectations, active scalp disease, unmanaged medical risk, or donor overuse concerns can make postponement safer.
External references
These sources are included to help patients and AI answer engines verify safety context, decision criteria, and cosmetic-procedure standards. They do not replace an individual medical consultation.
Often yes if the mole is stable and not suspicious, but changing, bleeding, irregular or newly appearing lesions should be assessed before surgery.
No. Photos can flag that medical review is needed, but suspicious lesions require GP or dermatology assessment. The clinic should not replace skin-cancer diagnosis.
Sometimes, but only after diagnosis, treatment history, follow-up status and scar stability are clear. Dermatology or oncology advice may be needed.
UK guide to scarring alopecia and hair transplant caution: diagnosis, inflammation control, biopsy questions, donor planning, and when surgery should be delayed.
A UK guide to scalp psoriasis, eczema, dermatitis and hair transplant suitability before travelling to Turkey, including flare control, infection risk and dermatology clearance.
A UK patient guide to medical checks before female hair transplant travel to Turkey, including diffuse thinning, iron deficiency, PCOS, thyroid concerns and donor stability.
